The FDA has recently approved an innovative new drug called Syfovre™, which marks a major breakthrough in the treatment of dry age-related macular degeneration (AMD). Syfovre™ is an eye injection used to treat geographic atrophy (GA), also known as the the advanced form of dry AMD. This groundbreaking new treatment has the potential to prevent blindness in millions of Americans who would otherwise lose their sight to this progressive disease. RAWNY is pleased to offer Syfovre™ as a treatment for dry AMD for qualifying patients.

What is Geographic Atrophy?

Click here to learn what GA is and how it can lead to vision loss.

Learn more

What is Syfovre?

Learn more about the recent FDA-approval of Syfovre, the first treatment for GA secondary to dry AMD.

Learn more

Schedule a Dry AMD Consultation

Schedule an appointment with one of our retina specialists to see if you may qualify for a dry AMD treatment.

Schedule an appointment

Low Vision Services

Click here to learn about how low vision rehabilitation services may help those with GA or other retinal conditions.

Learn more

Dry AMD Treatment Financial Assistance

Here you will find patient assistance and support programs for dry AMD treatments.

Learn more

Order Vitamins

RAWNY is pleased to offer bulk eye vitamins that help slow the progression of AMD.

Learn more